(Q34579905)

3 August 2017

1 reference

title

Immunisations in solid-organ transplant recipients (English)

1 reference

3 August 2017

Klaus Stark

1

1 reference

3 August 2017

Matthias Günther

2

1 reference

3 August 2017

Christian Schönfeld

3

1 reference

3 August 2017

Stefan G Tullius

4

1 reference

3 August 2017

Ulrich Bienzle

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

359

1 reference

3 August 2017

issue

9310

1 reference

3 August 2017

page(s)

957-965

1 reference

Improved graft survival after renal transplantation in the United States, 1988 to 1996

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

T cell-dependent B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The development and repertoire of B-1 cells (CD5 B cells)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Pharmacology of immunosuppressive medications used in renal diseases and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Rapamycin in transplantation: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunity to diphtheria and tetanus in a young population on a dialysis regimen or with a renal transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Duration of immunity to diphtheria and tetanus in young kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Routine immunizations in adult renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunity to poliomyelitis, diphtheria and tetanus in pediatric patients before and after renal or liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Influenza infection in patients before and after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Prevention and treatment of influenza in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Influenza vaccination in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The immunogenicity of influenza virus vaccine in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Efficacy of influenza vaccination in adult liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Influenza vaccination following liver transplantation in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Antibody response to influenza immunization in patients after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Suppression of the humoral immune response by mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Evidence of serious graft damage induced by de novo hepatitis B virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Use of licensed vaccines for active immunization of the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Response to hepatitis B vaccination by liver transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Prevention of fungal and hepatitis virus infections in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Differences between cyclosporin A and tacrolimus in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

New 23-valent pneumococcal vaccine in relation to pneumococcal serotypes in systemic and non-systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Pneumococcal vaccine response in cirrhosis and liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immunogenicity of pneumococcal vaccine in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Lengthy tale of varicella vaccine development finally nears a clinically useful conclusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Varicella and zoster in children after kidney transplantation: long-term results of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Attenuated varicella virus vaccine in children with renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Response to measles-mumps-rubella vaccine in children on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Measles vaccination after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Immune response to Haemophilus influenzae type B vaccination in renal transplant recipients with well-functioning allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

Haemophilus influenzae immunisation and timing of cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908028-5

7 January 2021

10.1016/S0140-6736(02)08028-5

Identifiers

DOI

1 reference

3 August 2017

1 reference